Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
97.544,12
-0,22%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Immunocore Holdings PLC (IMCR) Immunocore Holdings PLC (IMCR) Notizie

Immunocore Holdings PLC

IMCR
28,325
-0,095 (-0,33%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/12/202413:00GLOBEImmunocore announces treatment of first patient in the Phase..
11/12/202413:00GLOBEEORTC and Immunocore announce enrolment of first patient..
03/12/202407:00GLOBEImmunocore announces reimbursement agreement in England for..
08/11/202422:20EDGAR2Form 8-K - Current report
08/11/202413:00GLOBEImmunocore to present at upcoming investor conferences
06/11/202413:22EDGAR2Form 8-K - Current report
06/11/202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202413:00GLOBEImmunocore reports third quarter financial results and..
16/9/202412:46EDGAR2Form 8-K - Current report
14/9/202409:00GLOBEImmunocore presents Phase 1 data of brenetafusp, an ImmTAC..
12/9/202422:05GLOBEImmunocore to present at the 2024 Cantor Global Healthcare..
10/9/202419:49EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
29/8/202413:21EDGAR2Form 8-K - Current report
29/8/202413:00GLOBEImmunocore announces transition of Chief Financial Officer
08/8/202413:21EDGAR2Form 8-K - Current report
08/8/202413:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:00GLOBEImmunocore reports second quarter financial results and..
01/8/202413:00GLOBEImmunocore to report second quarter 2024 financial results..
18/6/202413:00GLOBEImmunocore announces randomization of first patient in the..
01/6/202414:00GLOBEImmunocore presents KIMMTRAK clinical data demonstrating..
31/5/202422:21EDGAR2Form 8-K - Current report
31/5/202422:05GLOBEImmunocore reports updated Phase 1 data of brenetafusp..
30/5/202422:00GLOBEImmunocore to present at the Jefferies Global Healthcare..
29/5/202413:00GLOBEImmunocore converts Phase 2/3 TEBE-AM clinical trial into..
28/5/202422:17EDGAR2Form 8-K - Current report
28/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:50EDGAR2Form 8-K - Current report
08/5/202413:13EDGAR2Form 8-K - Current report
08/5/202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202413:00GLOBEImmunocore reports first quarter financial results and..
24/4/202416:00GLOBEImmunocore announces upcoming presentation and posters at..
04/4/202422:00GLOBEImmunocore to present at upcoming investor conferences
05/3/202422:30GLOBEImmunocore presented two posters at CROI 2024
01/3/202413:00GLOBEImmunocore to present at upcoming investor conferences
28/2/202422:19EDGAR2Form 8-K - Current report
28/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202413:34GLOBEImmunocore reports fourth quarter and full year 2023..
28/2/202413:33EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202400:46EDGAR2Form 144 - Report of proposed sale of securities
22/2/202413:00GLOBEImmunocore announces clinical trial collaboration and supply..
21/2/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202413:00GLOBEImmunocore to report fourth quarter and full year 2023..
02/2/202422:05EDGAR2Form 8-K - Current report
31/1/202405:30GLOBEImmunocore Prices Upsized Convertible Senior Notes Offering
Apertura: 28,70 Min: 27,79 Max: 29,29
Chiusura: 28,42

La tua Cronologia

NASDAQ
IMCR
Immunocore
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network